About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Massachusetts | 508 Studies

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 508 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 441-460 of 508 trials

CompletedEarly Changes In Multiparametric MRI In Prostate CancerIn this research study, the investigators are trying to determine if there are measurable changes in prostate MRI that will help predict those who will or will not respond to…NCT01959542·Boston, Massachusetts and 1 other CompletedEvaluating the Shared Decision Making Process Scale in Cancer Screening DecisionsThe purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a…NCT04601272·Boston, Massachusetts CompletedToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone.NCT00129142·Homewood, Alabama and 154 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor…NCT06855277·Homewood, Alabama and 99 others

CompletedA Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate CancerThe purpose of this study is to evaluate safety and efficacy of abiraterone acetate plus leuprolide acetate and prednisone, versus leuprolide acetate alone in male participants…NCT00924469·Boston, Massachusetts and 3 others

CompletedSurgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerRATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells.NCT00023686·Little Rock, Arkansas and 35 others

RecruitingStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsThis is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity…NCT05176483·Phoenix, Arizona and 121 others

CompletedTecemotide (L-BLP25) in Prostate CancerThis study examines tecemotide (L-BLP25) in combination with standard treatment for prostate cancer.NCT01496131·Rockland, Massachusetts

CompletedMultimodal Machine Learning Characterization of Solid TumorsThis research study wants to develop advanced imaging methods to more accurately characterize prostate cancer or solid tumor aggressiveness.NCT04687969·Boston, Massachusetts

Active not recruitingEnzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate CancerThe purpose of this study is to determine the effectiveness of enzalutamide, versus a conventional non-steroidal anti androgen (NSAA), when combined with a luteinizing hormone…NCT02446405·Boston, Massachusetts and 81 others

CompletedOPTimizing Treatment Focused Genetic Testing IN CancerThis two-part randomized controlled trial aims to evaluate the impact of pre-test video education as compared to pre-test Chatbot education.NCT04066361·Boston, Massachusetts

CompletedOnline Trial Examining Validity and Reliability of the Shared Decision Making Process SurveyThe purpose of this study is to survey a sample of adults who have recently made a decision about treatment of high cholesterol or high blood pressure or a decision about…NCT04317690·Boston, Massachusetts

TerminatedA Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)The purpose of this study is to determine if the addition of study drug (custirsen) can provide durable pain palliation for castrate resistant prostate cancer patients receiving…NCT01083615·La Verne, California and 32 others

CompletedARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate CancerThe purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).NCT00959959·Los Angeles, California and 7 others

TerminatedConventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADTThis research study is being offered to those patients who have received radiation therapy and who are receiving long-term hormonal therapy for their prostate cancer and whose PSA…NCT03777982·Boston, Massachusetts and 4 others

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

RecruitingStudy of DCC-2812 in Participants With Advanced Genitourinary CancersThis is a multicenter clinical trial to evaluate the safety and preliminary activity of the selective general control nonderepressible 2 (GCN2) activator DCC-2812 as monotherapy…NCT06966024·Boston, Massachusetts and 7 others

CompletedAndrogen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideThis is a prospective, randomized, open-label phase II study comparing cognitive outcomes between men with metastatic and non-metastatic castration resistant prostate cancer…NCT04335682·San Francisco, California and 7 others

Active not recruitingMulti-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaThe purpose of this study is to test if treatment with medications that reduce the male hormone level in the participant's body for a few months before surgery can shrink prostate…NCT03436654·Chicago, Illinois and 10 others

TerminatedNBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaThis study is a Phase 1/2 open-label involving 2 groups of patients newly diagnosed with either unfavorable intermediate risk or high risk prostate adenocarcinoma.NCT02805894·Boston, Massachusetts and 1 other

PreviousPage 23 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma